Literature DB >> 27499977

Minimally invasive surgery for esophageal achalasia.

Huan-Wen Chen1, Ming Du1.   

Abstract

Esophageal achalasia is due to the esophagus of neuromuscular dysfunction caused by esophageal functional disease. Its main feature is the lack of esophageal peristalsis, the lower esophageal sphincter pressure and to reduce the swallow's relaxation response. Lower esophageal muscular dissection is one of the main ways to treat esophageal achalasia. At present, the period of muscular layer under the thoracoscope esophagus dissection is one of the treatment of esophageal achalasia. Combined with our experience in minimally invasive esophageal surgery, to improved incision and operation procedure, and adopts the model of the complete period of muscular layer under the thoracoscope esophagus dissection in the treatment of esophageal achalasia.

Entities:  

Keywords:  Video-assisted thoracic surgery (VATS); esophageal achalasia; minimally invasive surgery

Year:  2016        PMID: 27499977      PMCID: PMC4958848          DOI: 10.21037/jtd.2016.06.35

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  8 in total

1.  Six years of experience in laparoscopic surgery of esophageal achalasia.

Authors:  A F Fernández; M A Martínez; J Ruiz; R Torres; B Faife; J R Torres; C M Escoto
Journal:  Surg Endosc       Date:  2002-10-29       Impact factor: 4.584

2.  Botulin toxin type A (BTA) for esophageal achalasia: a double-edged sword.

Authors:  Giuliana Galassi; Cristina Orlandi; Franco Valzania; Giovanna Albertini; Alberto Barbieri
Journal:  Int J Colorectal Dis       Date:  2010-11-04       Impact factor: 2.571

Review 3.  Pharmacologic therapy in treating achalasia.

Authors:  W A Hoogerwerf; P J Pasricha
Journal:  Gastrointest Endosc Clin N Am       Date:  2001-04

Review 4.  Minimally invasive surgery for esophageal achalasia.

Authors:  Luigi Bonavina
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

5.  Clinical results of thoracoscopic Heller's myotomy in the treatment of achalasia.

Authors:  M Codispoti; S Y Soon; G Pugh; W S Walker
Journal:  Eur J Cardiothorac Surg       Date:  2003-10       Impact factor: 4.191

6.  Long-term outcome of pneumatic dilation in the treatment of achalasia.

Authors:  Michael Hulselmans; Tim Vanuytsel; Toon Degreef; Daniel Sifrim; Willy Coosemans; Toni Lerut; Jan Tack
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-25       Impact factor: 11.382

7.  Impact of minimally invasive surgery on the treatment of esophageal achalasia: a decade of change.

Authors:  Marco G Patti; Piero M Fisichella; Silvana Perretta; Carlos Galvani; Maria V Gorodner; Thomas Robinson; Lawrence W Way
Journal:  J Am Coll Surg       Date:  2003-05       Impact factor: 6.113

8.  Thoracoscopic esophagomyotomy. Initial experience with a new approach for the treatment of achalasia.

Authors:  C Pellegrini; L A Wetter; M Patti; R Leichter; G Mussan; T Mori; G Bernstein; L Way
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.